How should leading enterprises in China's orthopaedic trauma industry enhance their international influence?
China's traumatic orthopedic industry is one of the important branches of the overall orthopedic industry, and many local medical device companies are deeply engaged in it. China's orthopaedic trauma market is also the fertile land with the highest production in China, pregnant with a number of local enterprises that can compete with foreign medical device giants in the future. Before entering the international high-end trauma orthopedic device market, Chinese enterprises in China's trauma orthopedic industry also have many problems to be solved, and some foundations need to be consolidated, so as to firmly grasp the independent R & D right and supply capacity of medical materials related to trauma orthopedic implant devices; Continuously improve the manufacturing and process level of Chinese medical devices, which will also enhance the competitiveness of Chinese enterprises in the whole Chinese orthopedic market
The overall trend of China's orthopaedic trauma industry is upward, and the market scale is expanding
Since western orthopaedic surgery was introduced into Chinese medical system in 1937, trauma orthopaedics has also experienced 84 years of development and reform. By the end of 2020, China's orthopaedic trauma market reached 9.4 billion yuan, accounting for 27.5% of the overall orthopaedic market; It is estimated that by the end of 2025, the scale of China's orthopaedic trauma market will reach 16.6 billion yuan, accounting for 23.6% of the overall orthopaedic market. The development of orthopaedic trauma industry depends on the aging population, the increasing number of sports injury population and the support and promotion of relevant national policies
China's trauma Orthopedics Market is highly localized, and Chinese enterprises are strong. It is expected to further expand the market share of Chinese enterprises in the future
China's orthopaedic trauma industry is the most industrialized segment of the orthopaedic market in China, but it presents the characteristics of scattered, small and miscellaneous as a whole. By the end of 2020, the overall revenue of Chinese enterprises accounting for the top 5 market share of China's orthopaedic trauma was RMB 1.77 billion, accounting for only 18.8% of the market share. Compared with the global trauma orthopedic market, Johnson & Johnson orthopedics and Shrek have reached 62% of the total market share, showing a market pattern of one super three strong as a whole. This may be one of the trends in the development of China's trauma department of orthopedics. China's policy on localization of medical devices will further expand the market scale of local trauma medical devices.
Focusing on the R & D and production of high-quality medical materials, the manufacturing and process level of medical devices, and the R & D of new technologies will be the tickets for Chinese trauma orthopedic medical devices companies to enter the international high-end device market
Compared with the international leaders in trauma orthopedics, Chinese enterprises should focus on the R & D and production of high-quality medical materials, such as bioceramics, medical titanium alloy and other raw materials. This is related to the cost and pricing power of high-value medical devices, and it is also the core of the future competition between Chinese Orthopaedic Trauma equipment companies and even Chinese Orthopaedic enterprises with international leaders; The second is to further improve the manufacturing level and quality control of trauma implant devices; It is also an important way to enhance the international competitiveness of Chinese enterprises to develop and produce new scientific and technological means as soon as possible, such as 3D printing, surgery Siasun Robot&Automation Co.Ltd(300024) and other related technologies
